Antidepressants are occasionally associated with tinnitus (Robinson, 2007). For example, Tandon (1987) reported that 1% of those taking imiprimine complained of tinnitus. In a double-blind trial of paroxetine for tinnitus, 3% discontinued due to a perceived worsening of tinnitus (Robinson, 2007). There are case reports concerning tinnitus as a withdrawal symptom from Venlafaxine and sertraline (Robinson, 2007). In our clinical practice, we have occasionally encountered patients reporting worsening of tinnitus with an antidepressant, generally in the SSRI family.
Schecklmann et al (2014) suggested that tinnitus is associated with alterations in motor cortex excitability, by pooling several studies, and reported that there are differences in intracortical inhibition, intra-cortical facilitation, and cortical silent period. We doubt that this means that motor cortex excitability causes tinnitus, but rather we suspect that these findings reflect features of brain organization that may predispose certain persons to develop tinnitus over someone else.
Research shows a frequent correlation between tinnitus and hearing loss. Because tinnitus is perceived differently by each sufferer, an exact diagnosis is essential. A doctor may conduct ENT, dental, orthodontic, and orthopedic examinations in order to establish whether a case can be medically treated or not. The pitch and volume of tinnitus can be determined by special diagnostic test, and a hearing test can reveal whether hearing loss is also involved. Treatment with hearing aids is often the first step to relief from tinnitus. Hearing aids compensate for hearing loss, which enables concentration on external sounds instead of internal noises.
Due to the large variability in tinnitus, a one-size-fits-all approach (as offered by maskers) will have limited benefits. Indeed, there is evidence that being able to customize a sound therapy (e.g., using the tinnitus pitch or hearing loss profile), will provide greater benefits7,8 for tinnitus sufferers. Given the evidence supporting this line of thinking and the limitations of existing tinnitus management options, we were driven to develop and rigorously test an enjoyable, personalized sound therapy that has potential to provide lasting relief to tinnitus sufferers.
Unfortunately that means tinnitus is a very complicated condition that involves several systems of the body. The good news, though, is that as doctors and researchers have developed a better understanding of the mechanisms behind tinnitus, they’ve also been able to develop new and promising treatments that target the brain rather than the ear — and have more of a chance of actually reversing the problem.
When there does not seem to be a connection with a disorder of the inner ear or auditory nerve, the tinnitus is called nonotic (i.e. not otic). In some 30% of tinnitus cases, the tinnitus is influenced by the somatosensory system, for instance people can increase or decrease their tinnitus by moving their face, head, or neck. This type is called somatic or craniocervical tinnitus, since it is only head or neck movements that have an effect.
Millions of Americans experience tinnitus, often to a debilitating degree, making it one of the most common health conditions in the country. The U.S. Centers for Disease Control estimates that nearly 15% of the general public — over 50 million Americans — experience some form of tinnitus. Roughly 20 million people struggle with burdensome chronic tinnitus, while 2 million have extreme and debilitating cases.1